Clinical Trial Update: Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combined atezolizumab with carboplatin and etoposide as neoadjuvant therapy for limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Small-cell Lung Cancer, Neoadjuvant Therapy | Phase 2 | Status: UNKNOWN